View Document Preview and Link Document Date: 2014-01-13 09:31:49 Open Document File Size: 1,32 MB Share Result on Facebook
Company Celgene / BP / / Event FDA Phase / / Facility Baylor College of Medicine September / / MedicalCondition Chronic Hodgkin's Lymphoma / lymphoma Myeloma TCR / EBV Specific CTLs Expressing CD19 CARs B-Cell Non-Hodgkin’s Advanced B-Cell Non Lymphoma / indication/Research Participant population Neuroblastoma Neuroblastoma TCR / Neuroblastoma PROTOCOL / number/title Disease / Infusion Tumor / CD30 Chimeric Antigen Receptor Disease / Trials Disease / / Organization Administration of Peripheral Blood T-Cells / Disclosure Center for Cell and Gene Therapy / Administration of EBV CTLs Expressing CD30 Chimeric Receptors PROTOCOL / Helen Heslop Institution / Baylor College of Medicine / / Position Challenges Investigator / / Product GD2 / CD30 / Adoptive Transfer / Administration / CD3 / CD19 / / SportsEvent NHL / / Technology Gene Therapy / indication/Research Participant population PROTOCOL / Cell Receptors / / SocialTag 
T Cell ImmunotherapyOptimizing Trial Design Session I Current Status of Cancer Immunotherapy: Trials, Results, and Challenges Investigator: Helen Heslop Institution: Baylor College of Medicine